An estimate of the total number of true human miRNAs

…, U Fischer, C Backes, V Galata… - Nucleic acids …, 2019 - academic.oup.com
While the number of human miRNA candidates continuously increases, only a few of them
are completely characterized and experimentally validated. Toward determining the total …

PLSDB: a resource of complete bacterial plasmids

V Galata, T Fehlmann, C Backes… - Nucleic acids …, 2019 - academic.oup.com
The study of bacterial isolates or communities requires the analysis of the therein included
plasmids in order to provide an extensive characterization of the organisms. Plasmids …

[HTML][HTML] PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data

L De Nies, S Lopes, SB Busi, V Galata… - Microbiome, 2021 - Springer
Background Pathogenic microorganisms cause disease by invading, colonizing, and
damaging their host. Virulence factors including bacterial toxins contribute to pathogenicity. …

Evaluating the use of circulating microRNA profiles for lung cancer detection in symptomatic patients

…, M Kahraman, N Ludwig, C Backes, V Galata… - JAMA …, 2020 - jamanetwork.com
Importance The overall low survival rate of patients with lung cancer calls for improved
detection tools to enable better treatment options and improved patient outcomes. Multivariable …

[HTML][HTML] miRNAs can be generally associated with human pathologies as exemplified for miR-144

…, B Vogel, C Backes, A ElSharawy, V Galata… - BMC medicine, 2014 - Springer
Background miRNA profiles are promising biomarker candidates for a manifold of human
pathologies, opening new avenues for diagnosis and prognosis. Beyond studies that describe …

BusyBee Web: metagenomic data analysis by bootstrapped supervised binning and annotation

CC Laczny, C Kiefer, V Galata, T Fehlmann… - Nucleic acids …, 2017 - academic.oup.com
Metagenomics-based studies of mixed microbial communities are impacting biotechnology,
life sciences and medicine. Computational binning of metagenomic data is a powerful …

[HTML][HTML] High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer

P Leidinger, T Brefort, C Backes, M Krapp, V Galata… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Validation of biomarkers is essential to advance the translational process to clinical
application. Although there exists an increasing number of reports on small non-coding RNAs (…

Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson's disease—the RESISTA-PD trial

…, L Gröger, N Grammes, V Galata… - Genomics …, 2022 - academic.oup.com
The composition of the gut microbiota is linked to multiple diseases, including Parkinson’s
disease (PD). Abundance of bacteria producing short-chain fatty acids (SCFAs) and fecal …

Prioritizing and selecting likely novel miRNAs from NGS data

…, N Ludwig, P Leidinger, B Vogel, V Galata… - Nucleic acids …, 2016 - academic.oup.com
Small non-coding RNAs play a key role in many physiological and pathological processes.
Since 2004, miRNA sequences have been catalogued in miRBase, which is currently in its …

Validating Alzheimer's disease micro RNAs using next-generation sequencing

…, C Deuschle, D Berg, C Ruschil, V Galata… - Alzheimer's & …, 2016 - Elsevier
Introduction Molecular biomarkers for Alzheimer's disease (AD) can support detection and
improved care for patients, but novel candidates require verification. We previously reported a …